Occupational Therapists in Danvers, MA Accepting Medicare

47 Occupational Therapists found. Showing 41 - 47

Kaitlin Flannery Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Independence Way, Danvers, MA 01923 Phone: 978-774-7570

Francine Elliott, OTRL CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 90 Lindall St, Danvers, MA 01923 Phone: 978-777-3740

Emily Staszak, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 149 Sylvan St, Danvers, MA 01923 Phone: 978-774-7570    Fax: 978-777-8547

Maral Kouyoumdjian Occupational Therapist Medicare: Medicare Enrolled Practice Location: 90 Lindall St, Danvers, MA 01923 Phone: 978-777-3740

Mrs. Michelle Tierney, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 63 Locust St, Danvers, MA 01923 Phone: 978-777-0011

Mary Lafleur Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 90 Lindall St, Danvers, MA 01923 Phone: 978-777-3740

Mrs. Catherine Nicole Tetzlaff Mundo, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 104 Endicott St Ste Ll02, Danvers, MA 01923 Phone: 617-724-0160

News Archive

Dundee and Bukwang Pharm announce partnership to develop new drug for Parkinson's

The University of Dundee's Drug Discovery Unit has announced a multi-million-pound partnership with Korea-based Bukwang Pharmaceutical Company in a bid to develop a new drug treatment for Parkinson's disease.

Alexza Pharmaceuticals announces development and commercialization collaboration with Biovail Laboratories International

Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.

Religion, spirituality boost hospital patients' satisfaction

Hospitalized patients who had conversations about religion and spirituality with the healthcare team were the most satisfied with their overall care. However, 20 percent of patients who would have valued these discussions say their desires went unmet, according to a new study by Joshua Williams from the University of Chicago and his colleagues.

Focused health actions may promote optimal food consumption behaviour, intense physical activity pattern

The University of Athens Medical School has conducted a comprehensive study to evaluate the relationship between diet quality, levels of physical activity and key lifestyle characteristics amongst a group of 12-17 year old schoolchildren. The objective was to determine the most appropriate health actions to reduce the risks of long-term cardiovascular disease. The study concludes that almost half of Greek schoolchildren have a low quality diet, while just 6 percent adhere to the traditional Mediterranean diet along with high levels of physical activity.

Read more Medical News

› Verified 4 days ago

• 1
• 2
• 3(current)